LENZ (LENZ Therapeutics) Float Percentage Of Total Shares Outstanding: 60.72% (As of Jul. 03, 2026)


LENZ LENZ Therapeutics Inc LENZ
12 GF Score
Price $5.89
! 2 Warning Signs
View Full Analysis

What is LENZ Therapeutics Float Percentage Of Total Shares Outstanding?

LENZ Therapeutics LENZ +1.73% 12 Float Percentage Of Total Shares Outstanding is 60.72% as of Jul. 03, 2026. GuruFocus rates LENZ with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LENZ Therapeutics's float shares is 19.04 Mil. LENZ Therapeutics's total shares outstanding is 31.35 Mil. LENZ Therapeutics's float percentage of total shares outstanding is 60.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LENZ Therapeutics's Insider Ownership is 0.67%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LENZ Therapeutics's Institutional Ownership is 109.91%.

LENZ
12GF Score
LENZ Therapeutics Inc LENZ
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LENZ Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

LENZ Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=19.04/31.35
=60.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 60.72% mean?
LENZ Therapeutics (LENZ) has a Float Percentage Of Total Shares Outstanding of 60.72% as of Jul. 03, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on LENZ Therapeutics and its competitors.
Is LENZ Therapeutics' Float Percentage Of Total Shares Outstanding too high?
LENZ Therapeutics' current Float Percentage Of Total Shares Outstanding is 60.72%. Overall, LENZ Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does LENZ Therapeutics' Float Percentage Of Total Shares Outstanding compare to KRRO and ANTX?
LENZ Therapeutics' Float Percentage Of Total Shares Outstanding of 60.72% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on LENZ Therapeutics and its competitors. LENZ Therapeutics's current Float Percentage Of Total Shares Outstanding is 60.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LENZ Therapeutics stock overvalued right now?
LENZ Therapeutics (LENZ) has a current Float Percentage Of Total Shares Outstanding of 60.72%. The current Float Percentage Of Total Shares Outstanding is 60.72%. LENZ Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For LENZ Therapeutics (LENZ), the current Float Percentage Of Total Shares Outstanding is 60.72% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LENZ Therapeutics Business Description

Address 201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA, USA, 92075
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
12GF Score

Get the complete analysis for LENZ

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.89
Price